4-Bromo-1-methyl-1H-pyrazole-3-carbonitrile, 95.0%, 250mg

2-(Oxazol-4-yl)phenol, 250mg

(R)-2-(4-Chlorophenyl)-2-hydroxyacetic acid, 95.0%, 10g

2,3,5-Trifluorobenzotrifluoride, 98.0%, 5g

E-Plan phase EPLPH 10x/0.25 objective. Working distance 6.61 mm

N-(2-acetylphenyl)acetamide, 98%, 5g

METHYL 3-BROMOMETHYL-4-CYANOBENZOATE, 95.0%, 250mg

Ribonucleic Acid Sodium Salt from Yeast25g

2-Amino-6-bromo-4-methoxyphenol>98.0%(HPLC)5g

TERT-BUTYL (2-CHLOROPYRIMIDIN-4-YL)(METHYL)CARBAMATE, 95.0%, 2g

Ethyl 1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl)piperidine-3-carboxylate, 95.0%, 100mg

Tobramycin, 25g

3,9-Bis[2-(3,5-diamino-2,4,6-triazaphenyl)ethyl]-2,4,8,10-tetraoxaspiro[5.5]undecane, 98%, 25g